Literature DB >> 7903781

p53 mutation hotspot in radon-associated lung cancer.

J A Taylor1, M A Watson, T R Devereux, R Y Michels, G Saccomanno, M Anderson.   

Abstract

Mutations in gene p53 are the most common defects in lung cancer and may be a pathway through which environmental carcinogens initiate cancer. We investigated p53 mutations in lung cancers from uranium miners with high radon exposure. 16 (31%) of 52 large-cell and squamous-cell cancers from miners contained the same AGG to ATG transversion at codon 249, including cancers from 3 or 5 miners who had never smoked. This specific mutation has been reported in only 1 of 241 published p53 mutations from lung cancers. The codon 249 mutation may be a marker for radon-induced lung cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903781

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.

Authors:  P Hainaut; T Soussi; B Shomer; M Hollstein; M Greenblatt; E Hovig; C C Harris; R Montesano
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  miR-19 in blood plasma reflects lung cancer occurrence but is not specifically associated with radon exposure.

Authors:  Olga Bulgakova; Dinara Zhabayeva; Assiya Kussainova; Alessandra Pulliero; Alberto Izzotti; Rakhmetkazhi Bersimbaev
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

4.  Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.

Authors:  R A Gjerset; H Fakhrai; D L Shawler; S Turla; O Dorigo; A Grover-Bardwick; D Mercola; S F Wen; H Collins; H Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

Review 5.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

6.  Ionizing radiation: future etiologic research and preventive strategies.

Authors:  S C Darby; P D Inskip
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

7.  Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation.

Authors:  Q Yang; H Wesch; K M Mueller; H Bartsch; K Wegener; M Hollstein
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.

Authors:  J Schneider; P Presek; A Braun; P Bauer; N Konietzko; B Wiesner; H J Woitowitz
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.

Authors:  D Matsuzoe; T Hideshima; K Ohshima; K Kawahara; T Shirakusa; A Kimura
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 10.  Biokinetics of nuclear fuel compounds and biological effects of nonuniform radiation.

Authors:  S Lang; K Servomaa; V M Kosma; T Rytömaa
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.